|
Direct-to-consumer drug advertisements increasing by drug companies In a March 19, 2001 issue of the American Medical
News appeared an article that dealt with the changes in MD's practices due
to drug companies increased advertising of prescription drugs directly to
the consumers. For decades the drug industry predominantly spent all
advertising efforts on getting doctors to prescribe their products. According to the article, in 1999, pharmaceutical companies spent about $1.8 billion on direct-to-consumer advertising. This represented an increase in spending of more than 1,000% since 1993. This was largely fueled by a boom in television advertising, which increased by more than 4,000% in that period. The numbers represent spending in thousands. TV ads Print ads
---------- ---------
1993 $24,879 $125,089
1994 $35,738 $229,798
1995 $54,816 $319,525
1996 $219,983 $564,697
1997 $309,584 $740,828
1998 $664,413 $630,387
1999 $1,127,107 $711,602
According to the National Institute for Health Care Management, a Washington, D.C., nonprofit, nonpartisan organization dedicated to improving the effectiveness, efficiency and quality of America's health care system, the most successfully promoted prescription drugs represent five categories: antidepressants, cholesterol-lowering agents, gastric acid reducers, oral antihistamines and antihypertensives. What most people may not be aware of is that drug ads need not receive Food and Drug Administration approval. However, the Federal Food, Drug, and Cosmetic Act requires that all drug advertisements contain, among other things, brief summary information regarding side effects, contraindications and effectiveness. Although some tout this new wave of advertising as a good thing, others see it as creating a problem between MDs and their patients. The article sums up this attitude by stating, "As a result, patients ask physicians about drugs they've seen advertised. Sometimes their questions provoke unpleasant confrontations."
|